Gamecard-Joyco Holdings,Inc. (TYO:6249)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	8,381	11,303	13,540	9,104	4,740	7,452
Short-Term Investments	27,997	26,994	18,789	17,295	21,902	18,399
Cash & Short-Term Investments	36,378	38,297	32,329	26,399	26,642	25,851
Cash Growth	14.27%	18.46%	22.46%	-0.91%	3.06%	-12.81%
Receivables	3,479	3,953	6,298	4,887	1,753	1,798
Inventory	11,986	10,216	9,821	6,173	3,451	2,296
Other Current Assets	688	4,964	4,920	4,780	4,827	4,283
Total Current Assets	52,531	57,430	53,368	42,239	36,673	34,228
Property, Plant & Equipment	509	546	552	456	426	367
Long-Term Investments	14,038	8,052	10,029	9,788	9,157	9,438
Other Intangible Assets	433	518	924	1,334	1,808	2,372
Long-Term Deferred Tax Assets	-	467	696	786	121	330
Other Long-Term Assets	1	1	1	-	1	1
Total Assets	67,512	67,014	65,570	54,603	48,186	46,736
Accounts Payable	3,421	3,044	3,341	4,003	2,291	657
Accrued Expenses	-	162	174	168	171	157
Current Portion of Leases	-	141	150	143	191	275
Current Income Taxes Payable	689	1,174	2,918	739	64	308
Other Current Liabilities	1,561	1,501	2,043	1,244	888	2,555
Total Current Liabilities	5,671	6,022	8,626	6,297	3,605	3,952
Long-Term Leases	-	256	303	232	259	350
Long-Term Deferred Tax Liabilities	-	6	-	-	8	-
Other Long-Term Liabilities	2,035	1,652	1,752	1,539	1,653	1,814
Total Liabilities	8,150	8,414	11,194	8,564	6,008	6,588
Common Stock	5,956	5,956	5,956	5,500	5,500	5,500
Additional Paid-In Capital	5,518	5,518	5,518	5,062	4,994	5,122
Retained Earnings	48,948	48,449	43,145	36,163	32,343	30,652
Treasury Stock	-1,347	-1,347	-28	-28	-747	-1,125
Comprehensive Income & Other	287	24	-215	-658	88	-1
Shareholders' Equity	59,362	58,600	54,376	46,039	42,178	40,148
Total Liabilities & Equity	67,512	67,014	65,570	54,603	48,186	46,736
Total Debt	-	397	453	375	450	625
Net Cash (Debt)	36,378	37,900	31,876	26,024	26,192	25,226
Net Cash Growth	14.27%	18.90%	22.49%	-0.64%	3.83%	-12.27%
Net Cash Per Share	2551.72	2629.21	2223.03	1875.33	1942.88	1852.44
Filing Date Shares Outstanding	14.02	14.02	14.66	14.24	13.66	13.34
Total Common Shares Outstanding	14.02	14.02	14.66	14.24	13.65	13.34
Working Capital	46,860	51,408	44,742	35,942	33,068	30,276
Book Value Per Share	4233.19	4178.85	3709.65	3233.14	3090.03	3009.64
Tangible Book Value	58,929	58,082	53,452	44,705	40,370	37,776
Tangible Book Value Per Share	4202.31	4141.91	3646.61	3139.46	2957.58	2831.83
Order Backlog	-	51	76	75	60	52

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.